Wendy C Weinberg

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Melanie E Royce, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, C J George Chang, Tiffany K Ricks, Krithika A Shetty, Jeffrey Kraft, Junshan Qiu, Pengfei Song, Rosane Charlab, Jingyu Yu, Kathryn E King, Anshu Rastogi, Brian Janelsins, Wendy C Weinberg, Kathleen Clouse, Vicky Borders-Hemphill, Lindsey Brown, Candace Gomez-Broughton, Zhong Li, Thuy Thanh Nguyen, Zhihao Qiu, Anh-Thy Ly, Suyoung Chang, Tingting Gao, Chi-Ming Tu, Bellinda King-Kallimanis, William F Pierce, Kelly Chiang, Clara Lee, Kirsten B Goldberg, John K Leighton, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Emine Guven-Maiorov, Nozomi Sakakibara, Roshini M Ponnamperuma, Kun Dong, Hector Matar, Kathryn E King, Wendy C Weinberg
Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry. Molecular carcinogenesis 61 (7) (2022)

Wendy C Weinberg.css-eqlu8i{font-size:small;padding-left:4px;}